Abstract
BackgroundInfliximab is a chimeric monoclonal antibody targeting tumor necrosis factor alpha (TNFα) indicated in active axial sponsyloarthritis (aSpA).ObjectivesWe determine association between blood levels of infliximab, antibodies toward infliximab (ATI), TNFα,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
